Extracted from this filing and checked against the source text.
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.99
LEXICON PHARMACEUTICALS, INC. entered into Purchase Agreement with Artal International S.C.A., Artal Group S.A., Artal International Management S.A., Invus Advisors, L.L.C., Invus Public Equities, L.P., Invus, L.P., Mr. Amaury Wittouck, Stichting Administratiekantoor Westend, Westend S.A. valued at 24,152,218 shares of common stock at Public Offering Price, total purchase price approx. $72.2 milli (effective 2023-05-31).
- Action
- entry
- Agreement
- equity purchase
- Counterparty
- Artal International S.C.A., Artal Group S.A., Artal International Management S.A., Invus Advisors, L.L.C., Invus Public Equities, L.P., Invus, L.P., Mr. Amaury Wittouck, Stichting Administratiekantoor Westend, Westend S.A.
- Value
- 24,152,218 shares of common stock at Public Offering Price, total purchase price approx. $72.2 milli
- Effective
- 2023-05-31
Exact text from the filing
On May 31, 2023, the Company entered into a Purchase Agreement (the “ Purchase Agreement ”) with Artal International S.C.A., Artal Group S.A., Artal International Management S.A., Invus Advisors, L.L.C., Invus Public Equities, L.P., Invus, L.P. (“ Invus ”), Mr. Amaury Wittouck, Stichting Administratiekantoor Westend and Westend S.A (collectively, the “ Invus Entities ”).
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.99
LEXICON PHARMACEUTICALS, INC. entered into Underwriting Agreement with Citigroup Global Markets Inc., Jefferies LLC, Piper Sandler & Co. valued at 23,924,705 shares of common stock at $2.60 per share, net proceeds approx. $66.9 million (effective 2023-05-31).
- Action
- entry
- Agreement
- underwriting
- Counterparty
- Citigroup Global Markets Inc., Jefferies LLC, Piper Sandler & Co.
- Value
- 23,924,705 shares of common stock at $2.60 per share, net proceeds approx. $66.9 million
- Effective
- 2023-05-31
Exact text from the filing
On May 31, 2023, Lexicon Pharmaceuticals, Inc. (the “ Company ”) entered into an Underwriting Agreement (the “ Underwriting Agreement ”) with Citigroup Global Markets Inc. (“ Citigroup ”), Jefferies LLC (“ Jefferies ”) and Piper Sandler & Co. (“ Piper Sandler ”), as representatives of the several underwriters named therein (the “ Underwriters ”), relating to a public offering (the “ Public Offering ”) of 23,924,705 shares (the “ Shares ”) of the Company’s common stock, par value $0.001 per share (“ Common Stock ”).
View on SEC.gov